Confounding mitigation for the exposure-response relationship of bevacizumab in colorectal cancer patients

Sarah Lobet1, Morgane Caulet2, Gilles Paintaud3,4

  • 1Inserm UMR 1069, Nutrition Croissance et Cancer, Tours University, Tours, France.

Abstract